PRIMARY SJÖGREN'S SYNDROME
Clinical trials for PRIMARY SJÖGREN'S SYNDROME explained in plain language.
Never miss a new study
Get alerted when new PRIMARY SJÖGREN'S SYNDROME trials appear
Sign up with your email to follow new studies for PRIMARY SJÖGREN'S SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for Sjögren's syndrome in early trial
Disease control CompletedThis phase 2 trial tested a biologic drug called RC18 in 42 people with primary Sjögren's syndrome, an autoimmune disease that causes dry eyes and mouth. Participants received weekly injections of either RC18 (at 160 mg or 240 mg) or a placebo for 24 weeks. The goal was to see if…
Matched conditions: PRIMARY SJÖGREN'S SYNDROME
Phase: PHASE2 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Sjögren's drug shows promise in safety extension trial
Disease control CompletedThis study looked at the long-term safety of efgartigimod in 24 adults with primary Sjögren's syndrome who had already completed a prior trial. Efgartigimod works by lowering certain antibodies that may drive the disease. The main goal was to track side effects over 48 weeks, wit…
Matched conditions: PRIMARY SJÖGREN'S SYNDROME
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New Sjögren's drug IBI355 enters human testing
Disease control CompletedThis early-stage trial tests an experimental drug called IBI355 in 30 adults with primary Sjögren's syndrome, an autoimmune disease that causes dry eyes and mouth. The main goal is to check the drug's safety and how the body processes it at different doses. Participants receive e…
Matched conditions: PRIMARY SJÖGREN'S SYNDROME
Phase: PHASE1 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 26, 2026 17:11 UTC
-
How many autoimmune patients try alternative therapies? new study counts
Knowledge-focused CompletedThis completed study surveyed 121 adults with autoimmune diseases like lupus, Sjögren's syndrome, or scleroderma. Participants filled out a questionnaire about their use of alternative medicines. The goal was to find out how common these practices are in this patient group.
Matched conditions: PRIMARY SJÖGREN'S SYNDROME
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Exercise program shows promise for rheumatic pain and mood
Knowledge-focused CompletedThis study looked at how a special exercise approach called BETY affects people with rheumatic diseases (like arthritis) who have chronic pain. Researchers reviewed past records of 300 participants to see if BETY improved their physical function, mood, and quality of life compare…
Matched conditions: PRIMARY SJÖGREN'S SYNDROME
Phase: NA • Sponsor: Eastern Mediterranean University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC